ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 120 filers reported holding ANIKA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $943,647 | +19.5% | 50,652 | +89.9% | 0.02% | +9.1% |
| Q4 2022 | $789,639 | +118.1% | 26,677 | +75.6% | 0.02% | +69.2% |
| Q3 2022 | $362,000 | -23.3% | 15,192 | -28.2% | 0.01% | -38.1% |
| Q2 2022 | $472,000 | +20.4% | 21,158 | +35.5% | 0.02% | +16.7% |
| Q1 2022 | $392,000 | +80.6% | 15,610 | +211.8% | 0.02% | 0.0% |
| Q2 2021 | $217,000 | -59.3% | 5,006 | -51.3% | 0.02% | -43.8% |
| Q4 2019 | $533,000 | +67.1% | 10,283 | +76.7% | 0.03% | +14.3% |
| Q3 2019 | $319,000 | -10.6% | 5,820 | -50.8% | 0.03% | +12.0% |
| Q1 2019 | $357,000 | +56.6% | 11,820 | +118.8% | 0.02% | +47.1% |
| Q3 2018 | $228,000 | -59.0% | 5,403 | -57.8% | 0.02% | -76.1% |
| Q1 2017 | $556,000 | +96.5% | 12,807 | +43.9% | 0.07% | +195.8% |
| Q3 2015 | $283,000 | -36.3% | 8,900 | -18.5% | 0.02% | -69.6% |
| Q4 2014 | $444,000 | – | 10,919 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |